Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Non-Current Assets (2016 - 2025)

STRATA Skin Sciences' Non-Current Assets history spans 14 years, with the latest figure at $1.2 million for Q3 2025.

  • For Q3 2025, Non-Current Assets fell 94.89% year-over-year to $1.2 million; the TTM value through Sep 2025 reached $1.2 million, down 98.82%, while the annual FY2024 figure was $1.3 million, 62.5% up from the prior year.
  • Non-Current Assets for Q3 2025 was $1.2 million at STRATA Skin Sciences, roughly flat from $1.2 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $36.0 million in Q1 2022 and bottomed at $600000.0 in Q4 2022.
  • The 5-year median for Non-Current Assets is $23.5 million (2024), against an average of $19.4 million.
  • The largest annual shift saw Non-Current Assets soared 100.0% in 2021 before it crashed 95.19% in 2025.
  • A 5-year view of Non-Current Assets shows it stood at $1.0 million in 2021, then tumbled by 40.0% to $600000.0 in 2022, then soared by 33.33% to $800000.0 in 2023, then soared by 62.5% to $1.3 million in 2024, then decreased by 7.69% to $1.2 million in 2025.
  • Per Business Quant, the three most recent readings for SSKN's Non-Current Assets are $1.2 million (Q3 2025), $1.2 million (Q2 2025), and $17.2 million (Q1 2025).